In vitro behavior of albumin-loaded carbonate hydroxyapatite gel

被引:26
作者
Barralet, JE
Aldred, S
Wright, AJ
Coombes, AGA
机构
[1] Univ Birmingham, Sch Dent, Biomat Unit, Birmingham B4 6NN, W Midlands, England
[2] Aston Univ, Astron Pharm Sch, Pharmaceut Sci Res Inst, Birmingham B4 7ET, W Midlands, England
[3] Univ Birmingham, Sch Chem, Birmingham B15 2TT, W Midlands, England
来源
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH | 2002年 / 60卷 / 03期
关键词
protein release; hydroxyapatite; carbonate apatite; delivery system; sol-gel;
D O I
10.1002/jbm.10070
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Hydroxyapatite (HA) powder, porous HA, plasma-sprayed HA, apatite cements, and sintered HA have all been investigated as delivery systems for compounds such as human growth hormone and vancomycin. However, many previous studies showed that the period of release was limited to 2-3 weeks. The concept of using a nanoporous matrix as a means of immobilizing proteins is well known but has largely been confined to silica-based systems. Carbonate hydroxyapatite (CHA) is more soluble in vivo than HA, and when formed as an aqueous precipitate, it is often formed as nanocrystals. This study investigated the release profiles of ovine albumin (OVA) from CHA gel stored in phosphate-buffered saline (PBS) and double distilled water (DDW) for times of up to 1 year. It was found that 7.9% OVA could be loaded onto apatitic gels by means of a purely aqueous process. This process provided a simple low-temperature method of protein adsorption on a high surface area apatitic matrix at physiological pH. The rate of short-term release of OVA was lower from CHA gels than from microcrystalline HA powder. However, the period of release from the CHA gel was short term and may have been associated with recrystallization of the gel. OVA loaded into CHA gel was found to remain undegraded in vitro at 37degreesC for periods of up to 1 year. (C) 2002 Wiley Periodicals, Inc.
引用
收藏
页码:360 / 367
页数:8
相关论文
共 50 条
[1]   CONTRIBUTION OF ELECTROSTATIC AND HYDROPHOBIC INTERACTIONS TO THE ADSORPTION OF PROTEINS BY ALUMINUM-CONTAINING ADJUVANTS [J].
ALSHAKHSHIR, RH ;
REGNIER, FE ;
WHITE, JL ;
HEM, SL .
VACCINE, 1995, 13 (01) :41-44
[2]  
AOKI H, 1994, MED APPL HYDROXYAPAT, P208
[3]  
Barralet J, 1998, J BIOMED MATER RES, V41, P79, DOI 10.1002/(SICI)1097-4636(199807)41:1<79::AID-JBM10>3.0.CO
[4]  
2-C
[5]  
Barralet J, 2000, J BIOMED MATER RES, V49, P176, DOI 10.1002/(SICI)1097-4636(200002)49:2<176::AID-JBM4>3.3.CO
[6]  
2-#
[7]  
Barralet JE, 1996, BIO-MED MATER ENG, V6, P101
[8]  
BARRALET JE, 1993, P 6 INT S CER MED OX, P179
[9]  
Blom EJ, 2000, J BIOMED MATER RES, V50, P67, DOI 10.1002/(SICI)1097-4636(200004)50:1<67::AID-JBM10>3.0.CO
[10]  
2-E